Literature DB >> 27408285

Role of Transpupillary Thermotherapy in Central Serous Chorio-Retinopathy.

V Mathur1, Jks Parihar2, R Maggon3, S K Mishra4.   

Abstract

BACKGROUND: To assess the efficacy of transpupillary thermo therapy (TTT) in cases of chronic central serous chorio- retinopathy (CSCR).
METHODS: A prospective evaluation was carried out on 25 cases of chronic CSCR who were subjected to TTT. Resolution of CSCR and improvement in visual acuity was noted after six weeks of therapy. RESULT: Out of 25 patients, 13 (52%) had complete success (resolution of CSCR and improvement in visual acuity > 2 lines on Snellen's chart), 10 (42%) had qualified success (resolution of CSCR but no improvement in visual acuity) and two (8%) had failure to therapy (no resolution of CSCR or improvement in visual acuity).
CONCLUSION: TTT maybe a good modality in aiding resolution of subretinal fluid in cases of chronic CSCR. However, improvement in visual function is dependent upon integrity of photo receptor layer of retina which is not influenced by this modality. A controlled study could be undertaken to compare outcome of TTT with conservative management in cases of early CSCR such that deleterious effects of chronic CSCR on the retinal photoreceptor layer are avoided.

Entities:  

Keywords:  Chronic central serous chorio- retinopathy; Macular volume; Retinal atrophy; Transpupillary thermo therapy

Year:  2011        PMID: 27408285      PMCID: PMC4921371          DOI: 10.1016/S0377-1237(09)80092-0

Source DB:  PubMed          Journal:  Med J Armed Forces India        ISSN: 0377-1237


  12 in total

1.  Histologic correlation of pig retina radial stratification with ultrahigh-resolution optical coherence tomography.

Authors:  Martin Gloesmann; Boris Hermann; Christian Schubert; Harald Sattmann; Peter K Ahnelt; Wolfgang Drexler
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-04       Impact factor: 4.799

2.  Five to 15 year follow-up of resolved idiopathic central serous chorioretinopathy.

Authors:  R Wong; A Chopdar; M Brown
Journal:  Eye (Lond)       Date:  2004-03       Impact factor: 3.775

3.  Visual prognosis in central serous choroidopathy: residual Amsler grid changes.

Authors:  S Jalali; A Gupta; I S Jain; J Ram
Journal:  Can J Ophthalmol       Date:  1991-08       Impact factor: 1.882

4.  Transpupillary thermotherapy for chronic central serous chorioretinopathy.

Authors:  Nazimul Hussain; Rohit Khanna; Anjli Hussain; Taraprasad Das
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-01-13       Impact factor: 3.117

5.  Transpupillary thermotherapy for subfoveal leaks in central serous chorioretinopathy.

Authors:  D Shukla; C Kolluru; T P Vignesh; S Karthikprakash; R Kim
Journal:  Eye (Lond)       Date:  2006-05-26       Impact factor: 3.775

6.  Apoptotic photoreceptor degeneration in experimental retinal detachment.

Authors:  B Cook; G P Lewis; S K Fisher; R Adler
Journal:  Invest Ophthalmol Vis Sci       Date:  1995-05       Impact factor: 4.799

7.  Retinal atrophy in idiopathic central serous chorioretinopathy.

Authors:  Maria S M Wang; Birgit Sander; Michael Larsen
Journal:  Am J Ophthalmol       Date:  2002-06       Impact factor: 5.258

8.  Role of photodynamic therapy in polypoidal choroidal vasculopathy.

Authors:  Nazimul Hussain; Anjli Hussain; Sundaram Natarajan
Journal:  Indian J Ophthalmol       Date:  2005-06       Impact factor: 1.848

9.  Transpupillary thermotherapy in the treatment of central serous chorioretinopathy.

Authors:  Song-Yang Wei; Chung-May Yang
Journal:  Ophthalmic Surg Lasers Imaging       Date:  2005 Sep-Oct

10.  Optical coherence tomography of central serous chorioretinopathy.

Authors:  M R Hee; C A Puliafito; C Wong; E Reichel; J S Duker; J S Schuman; E A Swanson; J G Fujimoto
Journal:  Am J Ophthalmol       Date:  1995-07       Impact factor: 5.258

View more
  1 in total

Review 1.  Non-resolving, recurrent and chronic central serous chorioretinopathy: available treatment options.

Authors:  Francesco Sartini; Michele Figus; Marco Nardi; Giamberto Casini; Chiara Posarelli
Journal:  Eye (Lond)       Date:  2019-03-01       Impact factor: 3.775

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.